Benjamin H Freed
Overview
Explore the profile of Benjamin H Freed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
1198
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mukherjee M, Rudski L, Addetia K, Afilalo J, DAlto M, Freed B, et al.
J Am Soc Echocardiogr
. 2025 Mar;
38(3):141-186.
PMID: 40044341
Right heart adaptation to pulmonary hypertension (PH) is a critical determinant of clinical outcomes, morbidity, and mortality in patients with or at risk for cardiopulmonary disease. The World Symposium on...
2.
Chen C, Nishtala A, Li E, Schultz W, Baldridge A, Groenendyk J, et al.
Int J Cardiovasc Imaging
. 2025 Feb;
PMID: 40009120
Systemic sclerosis (SSc) is an autoimmune disease that causes inflammation and fibrosis. Cardiac involvement in SSc is often subclinical and portends a worse prognosis. Autologous hematopoietic stem cell transplant (HSCT)...
3.
Freed B, Thenappan T
Am J Respir Crit Care Med
. 2025 Jan;
211(3):426-427.
PMID: 39879550
No abstract available.
4.
Kim B, Lee J, Berhane H, Freed B, Shah S, Thomas J
Pulm Circ
. 2025 Jan;
15(1):e70022.
PMID: 39749111
Pulmonary artery (PA) flow analysis is crucial for understanding the progression of pulmonary hypertension (PH). We hypothesized that PA flow characteristics vary according to PH etiology. In this study, we...
5.
Mukherjee M, Mathai S, Jellis C, Freed B, Yanek L, Agoglia H, et al.
Circ Cardiovasc Imaging
. 2024 Dec;
17(10).
PMID: 39691460
Background: Defining qualitative grades of echocardiographic metrics of right heart chamber size and function is critical for screening, clinical assessment, and measurement of therapeutic response in individuals with pulmonary vascular...
6.
Elbaz M, Shafeghat M, Freed B, Sarnari R, Zilber Z, Avery R, et al.
J Magn Reson Imaging
. 2024 Oct;
PMID: 39467263
Background: Pulmonary hypertension (PH) is a life-threatening. Differentiation pulmonary arterial hypertension (PAH) from pulmonary venous hypertension (PVH) is important due to distinct treatment protocols. Invasive right heart catheterization (RHC) remains...
7.
Koczo A, Reza N, Hayes S, Freed B, Gulati M, Merz N, et al.
JACC Adv
. 2024 Sep;
3(10):101213.
PMID: 39252858
No abstract available.
8.
Culler K, Sinha A, Filipp M, Giro P, Allen N, Taylor K, et al.
Sci Rep
. 2024 Sep;
14(1):20694.
PMID: 39237673
Metabolic comorbidities, such as obesity and diabetes, are associated with subclinical alterations in both cardiac structure/function and natriuretic peptides prior to the onset of heart failure (HF). Despite this, the...
9.
Rajagopal S, Bogaard H, Elbaz M, Freed B, Remy-Jardin M, van Beek E, et al.
Eur Respir J
. 2024 Aug;
64(4).
PMID: 39209480
Pulmonary hypertension (PH) remains a challenging condition to diagnose, classify and treat. Current approaches to the assessment of PH include echocardiography, ventilation/perfusion scintigraphy, cross-sectional imaging using computed tomography and magnetic...
10.
Freed B, DeFaria Yeh D, Davis M
JACC Adv
. 2024 Aug;
3(7):101006.
PMID: 39130010
No abstract available.